Rabxkem-DSR is a dual-action formulation combining Rabeprazole Sodium (20 mg, enteric-coated), a potent proton pump inhibitor that suppresses gastric acid secretion, with Domperidone (30 mg, sustained-release), a prokinetic agent that enhances gastric motility. This combination provides effective and long-lasting relief from acid-related gastrointestinal disorders associated with reflux, nausea, and bloating.
Indications:
-
Gastroesophageal reflux disease (GERD)
-
Peptic and duodenal ulcers
-
Chronic gastritis
-
Acid reflux with nausea or vomiting
-
Functional dyspepsia and bloating
Key Benefits:
-
Dual-action therapy: reduces stomach acid and enhances gastric emptying
-
Provides fast and long-lasting relief from acidity and reflux
-
Controls nausea, vomiting, and bloating linked with GERD
-
Promotes healing of acid-induced mucosal damage
-
Improves overall digestive comfort and patient compliance




Reviews
There are no reviews yet.